Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901-Reference-Cited by-同舟云学术

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

Published:2007-01 Issue:1 Volume:48 Page:97-103
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Czuczman Myron S.,Porcu Pierluigi,Johnson Jeffrey,Niedzwiecki Donna,Kelly Michael,Hsi Eric D.,Cook James R,Canellos George,Cheson Bruce D.,For the Cancer and Leukemia Group B

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600961058

Reference10 articles.

1. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

2. Evaluation of the Revised European-American Lymphoma Classification Confirms the Clinical Relevance of Immunophenotype in 560 Cases of Aggressive Non-Hodgkin's Lymphoma

3. Treatment of T-cell non-hodgkin’ lymphoma

4. Therapy for mycosis fungoides

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia;The Lancet Haematology;2023-06

2. Purine-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022

3. Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma;Expert Review of Hematology;2016-12-08

4. Nelarabine Associated Myotoxicity and Rhabdomyolysis;Case Reports in Hematology;2015

5. Past, present and future treatment strategies in peripheral T-cell lymphomas;International Journal of Hematologic Oncology;2014-08